Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 GDNF treatment in Parkinson's disease: time for controlled clinical trials?

× No keyword cloud information.

5 in total

1. Optimized quantities of GDNF overexpressed by engineered astrocytes are critical for protection of neuroblastoma cells against 6-OHDA toxicity.

Authors: Roya Safi; Mossa Gardaneh; Yasin Panahi; Nader Maghsoudi; Mohammad Zaefizadeh; Ehsan Gharib
Journal: J Mol Neurosci Date: 2011-10-04 Impact factor: 3.444

2. Long-term restoration of nigrostriatal system function by implanting GDNF genetically modified fibroblasts in a rat model of Parkinson's disease.

Authors: Deyi Duan; Hui Yang; Jingzhong Zhang; Jinlu Zhang; Qunyuan Xu
Journal: Exp Brain Res Date: 2004-10-12 Impact factor: 1.972

3. Sustained Delivery of Bioactive GDNF from Collagen and Alginate-Based Cell-Encapsulating Gel Promoted Photoreceptor Survival in an Inherited Retinal Degeneration Model.

Authors: Francisca S Y Wong; Calvin C H Wong; Barbara P Chan; Amy C Y Lo
Journal: PLoS One Date: 2016-07-21 Impact factor: 3.240

4. GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice.

Authors: Cang Chen; Xiuhua Li; Guo Ge; Jingwei Liu; K C Biju; Suzette D Laing; Yusheng Qian; Cori Ballard; Zhixu He; Eliezer Masliah; Robert A Clark; Jason C O'Connor; Senlin Li
Journal: Sci Rep Date: 2018-04-03 Impact factor: 4.379

5. Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson's Disease.

Authors: Cang Chen; Michael J Guderyon; Yang Li; Guo Ge; Anindita Bhattacharjee; Cori Ballard; Zhixu He; Eliezer Masliah; Robert A Clark; Jason C O'Connor; Senlin Li
Journal: Mol Ther Methods Clin Dev Date: 2019-11-26 Impact factor: 6.698

5 in total